Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients - discussion

2 September 2024 (16:00 - 16:15)

Organised by:

Video

Sign in for access options

3 More presentations in this session

Presentation thumbnail

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: combination therapy from Day 1

Doctor M. Lettino (Monza, IT)

Presentation thumbnail

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: PCSK9 inhibitors from Day 1

Doctor S. Mehta (Hamilton, CA)

Presentation thumbnail

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: together with anti-inflammatory therapy from Day 1

Professor M. Sabatine (Boston, US)

Access the full session

Session thumbnail

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients

The Event

Event poster

ESC Congress 2024

2 September 2024 16:00 CET

You may be interested in

Congress Session

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients

Congress Session

For high-risk patients it's 15 minutes to midnight on the acute coronary syndrome (ACS) clock: can we stop it?

Congress Session

Fine-tuning post-acute coronary syndrome cardio protection: the case for early and aggressive lipid-lowering

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources